Abstract 290: Formulation of tolerable protocols for combination regimens to control triple-negative breast cancer cell-derived xenograft tumor development in animals
2019 ◽
2019 ◽
Vol 29
(1)
◽
pp. 62-65
◽
2014 ◽
Vol 149
(1)
◽
pp. 81-89
◽